{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:43:06Z","timestamp":1780605786067,"version":"3.54.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"DOI":"10.7759\/cureus.86862","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:22:33Z","timestamp":1751037753000},"source":"Crossref","is-referenced-by-count":3,"title":["Nivolumab-Induced Lichenoid Eruption: A Case Report"],"prefix":"10.7759","author":[{"given":"Hugo J","family":"Leme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Magarreiro-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2019.31.3.345","article-title":"A case of nivolumab-induced lichen planus","volume":"31","author":"Oh SJ","year":"2019","unstructured":"Oh SJ, Choi YH, Byun HJ, et al.. A case of nivolumab-induced lichen planus. Ann Dermatol. 2019, 31:345-7. 10.5021\/ad.2019.31.3.345","journal-title":"Ann Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2021.09.022","article-title":"Umbilical lichen planus induced by nivolumab","volume":"98","author":"Martos-Cabrera L","year":"2023","unstructured":"Martos-Cabrera L, Llad\u00f3 I, Fern\u00e1ndez-Rico P, Butr\u00f3n-Bris B, Rodr\u00edguez-Jim\u00e9nez P. Umbilical lichen planus induced by nivolumab. An Bras Dermatol. 2023, 98:712-4. 10.1016\/j.abd.2021.09.022","journal-title":"An Bras Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12858","article-title":"Diverse types of dermatologic toxicities from immune checkpoint blockade therapy","volume":"44","author":"Curry JL","year":"2017","unstructured":"Curry JL, Tetzlaff MT, Nagarajan P, et al.. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol. 2017, 44:158-76. 10.1111\/cup.12858","journal-title":"J Cutan Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420943260","article-title":"Cutaneous immune-related adverse events (irAEs) to immune checkpoint inhibitors: a dermatology perspective on management","volume":"25","author":"Muntyanu A","year":"2021","unstructured":"Muntyanu A, Netchiporouk E, Gerstein W, Gniadecki R, Litvinov IV. Cutaneous immune-related adverse events (irAEs) to immune checkpoint inhibitors: a dermatology perspective on management. J Cutan Med Surg. 2021, 25:59-76. 10.1177\/1203475420943260","journal-title":"J Cutan Med Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.1912","article-title":"Timing of onset of adverse cutaneous reactions associated with programmed cell death protein 1 inhibitor therapy","volume":"154","author":"Wang LL","year":"2018","unstructured":"Wang LL, Patel G, Chiesa-Fuxench ZC, et al.. Timing of onset of adverse cutaneous reactions associated with programmed cell death protein 1 inhibitor therapy. JAMA Dermatol. 2018, 154:1057-61. 10.1001\/jamadermatol.2018.1912","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1136","article-title":"Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes","volume":"22","author":"Freeman-Keller M","year":"2016","unstructured":"Freeman-Keller M, Kim Y, Cronin H, Richards A, Gibney G, Weber JS. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin Cancer Res. 2016, 22:886-94. 10.1158\/1078-0432.CCR-15-1136","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.05.036","article-title":"Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage\u00a0III C melanoma","volume":"38","author":"Zemlok SK","year":"2023","unstructured":"Zemlok SK, Buuh S, Brown R, Murphy M, Hegde UP, Mallett JR. Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage\u00a0III C melanoma. JAAD Case Rep. 2023, 38:23-6. 10.1016\/j.jdcr.2023.05.036","journal-title":"JAAD Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382714-nivolumab-induced-lichenoid-eruption-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:22:33Z","timestamp":1751037753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382714-nivolumab-induced-lichenoid-eruption-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.86862","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}